antibodi
bind
linear
portion
gpcr
molecul
exampl
contigu
sequenc
ntermin
extracellular
domain
synthet
peptid
use
rapid
bind
evalu
two
differ
assay
format
use
convent
format
peptid
flow
captur
antibodi
differ
concentr
revers
format
flow
antibodi
immobil
peptid
three
mab
clone
use
evalu
compar
assay
format
shown
figur
convent
format
reproduc
kinet
data
tabl
obtain
howev
provid
suffici
resolut
sensit
differenti
mab
clone
reflect
konkoff
rate
map
shown
figur
contrast
revers
peptidebas
assay
format
abl
distinguish
mab
almost
slower
koffrat
tabl
reveal
convent
format
assay
konkoff
rate
map
figur
also
indic
revers
peptidebas
assay
format
display
good
reproduc
howev
sinc
antibodi
dimer
molecul
possibl
one
antibodi
molecul
could
bind
two
peptid
chip
surfac
therebi
result
artifici
high
affin
avid
effect
affin
kd
data
gener
revers
format
inde
higher
data
gener
convent
assay
format
therefor
higher
affin
data
antibodi
least
part
attribut
avid
effect
order
evalu
avid
effect
detail
differ
level
ru
equival
respect
biotinyl
peptid
captur
sa
chip
surfac
kinet
assay
perform
shown
figur
although
overal
antibodi
bind
ru
correl
peptid
level
captur
shape
sensorgram
antibodi
differ
peptid
densiti
similar
shown
figur
three
differ
peptid
immobil
level
show
similar
affin
result
wherea
clone
dramat
differ
highest
level
peptid
ru
inde
alter
overal
affin
kd
mainli
due
artifici
koff
tabl
outsid
biacor
accuraci
rang
koff
peptidebas
assay
antigpcr
antibodi
conveni
howev
use
analyz
antibodi
recogn
linear
epitop
convent
assay
format
lack
resolut
distinguish
three
mab
clone
test
wherea
revers
assay
format
lack
accuraci
due
avid
effect
develop
wholereceptor
assay
abl
address
issu
order
develop
gpcr
whole
receptor
assay
tandem
tag
ad
cterminu
fulllength
human
code
sequenc
express
insect
cell
use
baculoviru
express
vector
system
follow
method
describ
jaakola
vp
et
human
protein
purifi
mixtur
monom
dimer
trimer
figur
purifi
receptor
directli
captur
nta
spr
sensor
chip
via
nimedi
affin
captur
order
gener
stabl
chip
surfac
commonli
use
amin
coupl
reagent
nhsedc
respect
use
stabil
captur
receptor
surfac
test
ligand
bind
figur
antibodi
bind
figur
high
qualiti
kinet
data
obtain
follow
inject
ligand
antibodi
differ
concentr
receptor
surfac
order
assess
impact
avid
effect
captur
stabil
approach
chip
surfac
two
differ
receptor
densiti
ru
prepar
shown
figur
receptor
densiti
high
qualiti
kinet
sensorgram
gener
good
reproduc
konkoff
rate
map
figur
highlight
reproduc
triplic
data
point
three
antibodi
sampl
well
ligand
welldifferenti
assay
format
possibl
use
two
peptidebas
assay
format
kinet
data
shown
tabl
demonstr
reliabl
assay
regardless
differ
receptor
densiti
therefor
limit
chemic
crosslink
step
gener
stabl
sensor
chip
surfac
full
ligand
bind
activ
use
method
stabil
chip
surfac
regener
mm
hcl
repeat
cycl
without
notic
loss
bind
activ
extend
applic
capturestabil
approach
viruslik
particl
analyz
type
membran
protein
target
nativ
membran
environ
human
heavili
glycosyl
glycosylphosphatidylinositol
gpi
anchor
protein
compos
aa
use
exampl
shown
figur
viruslik
particl
vlp
prepar
cell
western
blot
analysi
verifi
presenc
vlp
prep
vlp
contain
captur
antibodi
chip
surfac
captur
vlp
stabil
approach
three
differ
monoclon
antibodi
slightli
differ
bind
epitop
chu
et
al
unpublish
data
includ
captur
antibodi
alemtuzumab
demonstr
good
bind
activ
kinet
assay
similar
niaffin
captur
purifi
captur
vlp
alemtuzumab
target
specif
post
captur
crosslink
step
stabil
vlp
surfac
enabl
multipl
kinet
bind
assay
cycl
perform
capturestabil
approach
purifi
gpcr
molecul
first
captur
directli
ninta
chip
surfac
via
ctermin
altern
antibodi
first
immobil
chip
similar
level
receptor
protein
captur
indirectli
chip
surfac
necessari
receptor
captur
meet
specif
requir
small
molecul
compound
bind
assay
case
receptor
molecul
captur
specif
via
subsequ
limit
crosslink
step
stabil
captur
receptor
molecul
therefor
essenti
start
materi
purifi
gpcr
protein
test
activ
ligand
bind
purif
method
use
adapt
jaakola
v
et
al
determin
crystal
structur
human
adenosin
receptor
complex
highaffin
subtypeselect
yield
activ
pure
gpcr
without
need
engin
stabil
receptor
requir
substanti
amount
stabil
step
receptor
bind
site
may
block
crosslink
reaction
dilut
standard
aminecoupl
reagent
ge
edc
gave
best
result
crosslink
edc
result
signific
loss
bind
activ
data
shown
also
test
five
crosslink
reagent
receptor
stabil
nta
chip
surfac
case
similar
result
obtain
data
shown
therefor
chose
edc
standard
stabil
reagent
receptor
surfac
stabil
simpl
crosslink
step
yield
suffici
bind
capac
analyz
antibodi
ligand
bind
importantli
limit
crosslink
step
kept
whole
receptor
surfac
stabl
surfac
resist
surfact
present
run
buffer
also
allow
low
ph
ph
regener
step
featur
enabl
bind
assay
perform
condit
use
solubl
protein
result
high
qualiti
kinet
sensorgram
excel
reproduc
cv
assay
appli
success
eight
differ
gpcr
target
data
shown
expect
applic
gpcr
molecul
extend
applic
capturestabil
approach
viruslik
particl
demonstr
util
analyz
antibodi
alemtuzumab
specif
human
current
approv
treatment
bcell
chronic
lymphocyt
leukaemia
although
alemtuzumab
capabl
bind
nake
synthet
peptid
mab
clone
requir
glycan
part
bind
target
synthet
peptid
method
mab
viabl
option
viruslik
particl
captur
alemtuzumab
stabil
limit
crosslink
stabil
surfac
work
well
bind
kinet
assay
compar
type
antibodi
includ
captur
antibodi
vlp
produc
recombin
express
system
saccharomyc
cerevisia
report
nm
also
determin
vlp
produc
cell
similar
size
nm
data
shown
presum
portion
molecul
display
vlp
surfac
bound
captur
antibodi
unoccupi
molecul
therefor
avail
bind
analyt
antibodi
similarli
expect
approach
appli
type
membran
target
multitransmembran
domain
protein
ion
channel
conclus
demonstr
first
success
use
simpl
chemic
crosslink
step
stabil
captur
membran
protein
biacor
chip
surfac
result
membran
protein
surfac
remain
stabl
allow
multipl
round
consist
bind
analys
low
ph
regener
step
capturestabil
approach
provid
use
tool
analyz
antibodi
varieti
membran
protein
target
mous
antibodi
captur
kit
ge
use
biacor
chip
surfac
prepar
follow
standard
protocol
provid
manufactur
rabbit
antimous
polyclon
antibodi
ge
first
immobil
chip
surfac
via
amin
coupl
free
carboxyl
group
chip
surfac
use
standard
nhsedc
procedur
mous
monoclon
antibodi
clone
r
system
captur
antimous
antibodi
next
ntermin
peptid
mnypltlemd
lenledlfw
ldrldnyndt
slvenhlcpa
tegplmasfk
avfvp
inject
captur
antibodi
variou
concentr
gener
kinet
sensorgram
ctermin
biotinyl
peptid
mnypltlemd
lenledlfw
ldrldnyndt
slvenhlcpa
tegplmasfk
avfvpcbiotin
captur
streptavidin
biacor
sa
chip
surfac
specifi
densiti
unus
biotinbind
site
block
free
biotin
set
monoclon
antibodi
use
convent
assay
inject
variou
concentr
gener
biacor
kinet
sensorgram
human
receptor
express
cell
use
fastbac
express
system
invitrogen
cell
grown
suspens
flask
serumfre
medium
cell
infect
recombin
viru
densiti
cellsml
viru
ad
multipl
infect
moi
equal
volum
fresh
medium
ad
immedi
afterward
cell
harvest
centrifug
hour
postinfect
follow
jaakola
vp
harvest
cell
initi
disrupt
homogen
hypoton
buffer
contain
mm
hepe
ph
mm
kcl
mm
extens
wash
isol
raw
membran
perform
repeat
centrifug
typic
six
nine
time
highosmot
buffer
contain
nacl
mm
hepe
ph
mm
mm
kcl
proteas
inhibitor
cocktail
roch
follow
dounc
homogen
resuspend
membran
fresh
wash
buffer
therebi
separ
solubl
membraneassoci
protein
integr
transmembran
protein
highli
purifi
membran
solubil
incub
presenc
wv
ndodecyldmaltopyranosid
ddm
sigma
wv
cholesteryl
hemisuccin
ch
sigma
two
three
hour
solubil
unsolubil
materi
remov
centrifug
g
minut
supernat
separ
supplement
mm
buffer
imidazol
incub
ninta
resin
qiagen
overnight
typic
ml
resin
per
one
liter
origin
cultur
volum
use
bind
resin
wash
ten
column
volum
mm
hepe
ph
mm
nacl
vv
glycerol
mm
imidazol
wv
ddm
wv
ch
receptor
elut
mm
hepe
ph
mm
nacl
vv
glycerol
wv
ddm
wv
ch
mm
imidazol
elut
receptor
directli
ad
mab
coupl
affin
resin
presenc
mm
overnight
wash
mm
hepe
ph
mm
nacl
vv
glycerol
wv
ddm
wv
ch
mm
cacl
elut
mm
hepe
ph
mm
nacl
vv
glycerol
wv
ddm
wv
ch
mm
edta
elut
receptor
buffer
exchang
mm
hepe
ph
mm
nacl
vv
glycerol
wv
ddm
wv
ch
store
direct
nta
chip
captur
follow
min
inject
mm
purifi
receptor
concentr
ngml
dilut
hbsn
buffer
inject
flow
rate
achiev
captur
level
reson
unit
ru
depend
experi
purpos
niaffin
captur
receptor
protein
stabil
limit
crosslink
flow
mixtur
edc
nh
min
subsequ
excess
crosslink
quench
ethanolamin
min
surfac
stabil
receptor
chip
prime
run
buffer
subsequ
assay
step
end
bind
cycl
gpcr
surfac
regener
inject
mm
hcl
min
flow
rate
ulmin
mab
test
triplic
dilut
seri
bind
hbsep
run
buffer
sampl
inject
flow
rate
fulllength
code
sequenc
atgaagcgcttcctcttcctcctactcacca
tcagcctcctggttatggtacagatacaaactggactctcaggacaaaacgacaccagccaaaccagcagcccctcagcatccagcagcatgagcggaggcattttccttttcttcgtggccaatgccataatccacctcttctgcttcagttga
clone
vector
invitrogen
follow
user
guid
membraneprotm
function
protein
express
system
life
technolog
vlp
prep
obtain
activ
chip
surfac
standard
nhsedc
procedur
antibodi
alemtuzumab
immobil
vlp
captur
antibodi
ru
level
captur
vlp
stabil
limit
crosslink
use
edc
min
flow
rate
excess
crosslink
quench
inject
ethanolamin
min
kinet
assay
three
mab
concentr
nm
perform
biosensor
data
process
analysi
perform
use
biacor
evalu
softwar
ge
version
kinet
analys
data
local
fit
interact
model
cv
coeffici
variat
calcul
standard
deviat
stdev
divid
mean
